Literature DB >> 6476577

Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.

T M Craig, R L Huey.   

Abstract

Twenty calves (8 to 12 months old), naturally infected with Fasciola hepatica and Fascioloides magna, were obtained from Brazoria, Tex. They were randomly allotted to 3 treatment groups. One group (6 calves) was given the carrier without drug, the 2nd group (7 calves) was treated with triclabendazole at 6 mg/kg of body weight, and the 3rd group (7 calves) was treated with triclabendazole at 12 mg/kg. All treatments were administered as a drench. Calves given triclabendazole (either dosage level) had a 100% reduction in F hepatica burden as compared with the untreated controls. Both treatment doses also appeared to have detrimental effect on F magna infections. Viability of all flukes was determined on the basis of movement, color, and tegumental integrity. Clinical toxic reactions were not observed in the treated calves.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476577

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Control of Fasciola gigantica with triclabendazole in Indonesian cattle.

Authors:  S Widjajanti; P Stevenson; I H Carmichael
Journal:  Trop Anim Health Prod       Date:  1991-11       Impact factor: 1.559

2.  Praziquantel failure in the treatment of Fasciola hepatica.

Authors:  D M Patrick; J Isaac-Renton
Journal:  Can J Infect Dis       Date:  1992-01

3.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 4.  Life history and biology of Fascioloides magna (Trematoda) and its native and exotic hosts.

Authors:  Miriama Malcicka
Journal:  Ecol Evol       Date:  2015-03-04       Impact factor: 2.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.